Literature DB >> 35738671

Adding MR Diffusion Imaging and T2 Signal Intensity to Neck Imaging Reporting and Data System Categories 2 and 3 in Primary Sites of Postsurgical Oral Cavity Carcinoma Provides Incremental Diagnostic Value.

A Jajodia1, G Mandal2, V Yadav2, J Khoda3, J Goyal3, S Pasricha4, S Puri3, A Dewan2.   

Abstract

BACKGROUND AND
PURPOSE: The NI-RADS lexicon doesn't use ADC parameters and T2 weighted signal for ascribing categories. We explored ADC, DWI, and T2WI to examine the diagnostic accuracy in primary sites of postsurgical oral cavity carcinoma in the Neck Imaging Reporting and Data System (NI-RADS) categories 2 and 3.
MATERIALS AND METHODS: We performed a retrospective analysis in clinically asymptomatic post-surgically treated patients with oral cavity squamous cell carcinoma who underwent contrast-enhanced MRI between January 2013 and January 2016. Histopathology and follow-up imaging were used to ascertain the presence or absence of malignancy in subjects with "new enhancing lesions," which were interpreted according to the NI-RADS lexicon by experienced readers, including NI-RADS 2 and 3 lesions in the primary site. NI-RADS that included T2WI and DWI (referred to as NI-RADS A) and ADC (using the best cutoff from receiver operating characteristic curve analysis, NI-RADS B) was documented in an Excel sheet to up- or downgrade existing classic American College of Radiology NI-RADS and calculate diagnostic accuracy.
RESULTS: Sixty-one malignant and 23 benign lesions included in the study were assigned American College of Radiology NI-RADS 2 (n = 33) and NI-RADS 3 (n = 51) categories. The recurrence rate was 90% (46/51) for NI-RADS three, 45% (15/33) for NI-RADS 2, and 73% (61/84) overall. T2WI signal morphology was intermediate in 45 subjects (53.5%) and restricted DWI in 54 (64.2%). Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the American College of Radiology NI-RADS were the following: NI-RADS (75.4%, 78.3%, 90.1%, 54.5%, and 76.1%); NI-RADS A (79.1%, 81.2%, 91.9%, 59.1%, and 79.6%); and NI-RADS B (88.9%, 72.7%, 91.4%, 66.7%, and 85.1%), respectively.
CONCLUSIONS: Adding MR imaging diagnostic characteristics like T2WI, DWI, and ADC to the American College of Radiology NI-RADS improved diagnostic accuracy and sensitivity.
© 2022 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2022        PMID: 35738671      PMCID: PMC9262069          DOI: 10.3174/ajnr.A7553

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   4.966


  18 in total

1.  Implementation of a Novel Surveillance Template for Head and Neck Cancer: Neck Imaging Reporting and Data System (NI-RADS).

Authors:  Ashley H Aiken; April Farley; Kristen L Baugnon; Amanda Corey; Mark El-Deiry; Richard Duszak; Jonathan Beitler; Patricia A Hudgins
Journal:  J Am Coll Radiol       Date:  2015-11-11       Impact factor: 5.532

2.  ACR Neck Imaging Reporting and Data Systems (NI-RADS): A White Paper of the ACR NI-RADS Committee.

Authors:  Ashley H Aiken; Tanya J Rath; Yoshimi Anzai; Barton F Branstetter; Jenny K Hoang; Richard H Wiggins; Amy F Juliano; Christine Glastonbury; C Douglas Phillips; Richard Brown; Patricia A Hudgins
Journal:  J Am Coll Radiol       Date:  2018-07-06       Impact factor: 5.532

3.  Interrater Reliability of NI-RADS on Posttreatment PET/Contrast-enhanced CT Scans in Head and Neck Squamous Cell Carcinoma.

Authors:  Derek Hsu; Tanya J Rath; Barton F Branstetter; Yoshimi Anzai; C Douglas Phillips; Amy F Juliano; Kristine M Mosier; Michael P Bazylewicz; Stan M Poliashenko; Matthew H Kulzer; Patricia A Rhyner; Benjamin Risk; Richard H Wiggins; Ashley H Aiken
Journal:  Radiol Imaging Cancer       Date:  2021-05

4.  Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.

Authors:  D A Krieger; P A Hudgins; G K Nayak; K L Baugnon; A S Corey; M R Patel; J J Beitler; N F Saba; Y Liu; A H Aiken
Journal:  AJNR Am J Neuroradiol       Date:  2017-03-31       Impact factor: 3.825

Review 5.  Updated National Comprehensive Cancer Network guidelines for treatment of head and neck cancers 2010-2017.

Authors:  Małgorzata Wierzbicka; Joanna Napierała
Journal:  Otolaryngol Pol       Date:  2017-12-30

6.  Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?

Authors:  W J Goodwin
Journal:  Laryngoscope       Date:  2000-03       Impact factor: 3.325

7.  Positive Predictive Value of Neck Imaging Reporting and Data System Categories 3 and 4 Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma.

Authors:  P Wangaryattawanich; B F Branstetter; J D Ly; U Duvvuri; D E Heron; T J Rath
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-28       Impact factor: 3.825

8.  Value of routine follow-up for patients cured of laryngeal carcinoma.

Authors:  Savitri C Ritoe; Paul F M Krabbe; Johannes H A M Kaanders; Frank J A van den Hoogen; André L M Verbeek; Henri A M Marres
Journal:  Cancer       Date:  2004-09-15       Impact factor: 6.860

9.  Reliability of NI-RADS criteria in the interpretation of contrast-enhanced magnetic resonance imaging considering the potential role of diffusion-weighted imaging.

Authors:  Fabian Henry Jürgen Elsholtz; Christoph Erxleben; Hans-Christian Bauknecht; Patrick Dinkelborg; Kilian Kreutzer; Bernd Hamm; Stefan Markus Niehues
Journal:  Eur Radiol       Date:  2021-02-03       Impact factor: 5.315

10.  MRI Posttreatment Surveillance for Head and Neck Squamous Cell Carcinoma: Proposed MR NI-RADS Criteria.

Authors:  M M Ashour; E A F Darwish; R M Fahiem; T T Abdelaziz
Journal:  AJNR Am J Neuroradiol       Date:  2021-03-11       Impact factor: 4.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.